What's new

Human medicines European public assessment report (EPAR): Hepcludex, bulevirtide, Date of authorisation: 31/07/2020, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR): Hepcludex, bulevirtide, Date of authorisation: 31/07/2020, Revision: 14, Status: Authorised

Feb 9, 2025 - 21:46
 0
Human medicines European public assessment report (EPAR): Hepcludex, bulevirtide, Date of authorisation: 31/07/2020, Revision: 14, Status: Authorised
Human medicines European public assessment report (EPAR): Hepcludex, bulevirtide, Date of authorisation: 31/07/2020, Revision: 14, Status: Authorised
Read More

Tags:

Previous Article

Central Nervous System Working Party

Next Article

Human medicines European public assessment report (EPAR): Omvoh, mirikizumab, Da...

Related Posts

Fees payable to the European Medicines Agency: Fees, charges and remuneration for assessment procedures and services relating to veterinary medicinal products

Fees payable to the European Medicines Agency: Fees, ch...

Apr 15, 2025  0

Human medicines European public assessment report (EPAR): Cinqaero, reslizumab, Date of authorisation: 15/08/2016, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 11, 2025  0

Herbal medicinal product: Equiseti herba, Equisetum arvense L., F: Assessment finalised

Herbal medicinal product: Equiseti herba, Equisetum arv...

Apr 1, 2025  0